Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2025-12-27 @ 10:22 PM
Study NCT ID:
NCT06834451
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-19
First Post:
2025-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Revolade® Eltrombopag 50 mg
Sponsor:
Centro de Atencion e Investigacion Medica
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-23
First Submit QC Date:
None
Study First Post Date:
2025-02-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-16
Last Update Post Date:
2025-06-19
Last Update Post Date Type:
ACTUAL